A medicine stock-out is defined by the World Health Organization (WHO) as “any time when, at a defined moment in a given ...

which says it will start clinical trials of the biosimilars this year with a view to filing for approval in 2023. They will use drug substance made by GeneSys Biologics but will be made at Civica ...

Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative ...